Shortly after we posted a breakdown on the incoming helium supply disruption from Qatar for our premium subscribers, ASP Isotopes announced that they had completed the well drilling required for Phase 1 of the Renergen Helium Project approximately four months ahead of schedule. The achievement marks a key operational milestone at the Virginia Gas Project in South Africa, substantially reducing execution risks for the planned helium and LNG production ramp.
The stock spiked higher on the news…
Drilling operations, which restarted in April 2025 following bridge loan funding from ASP Isotopes ahead of the Renergen acquisition, have now achieved the required cumulative nameplate flow rate. Results from the Phase 1C exploration campaign show gas flow rates that meet or exceed previously estimated type curves. Some recent wells delivered flows up to 16 times higher than earlier ones, thanks to improved exploration techniques and reservoir modeling by a U.S.-based expert team.
“This marks a watershed moment for our plans for helium production at the Virginia Gas Project,” said Paul Mann, Executive Chairman and CEO of ASP Isotopes. “This result, together with the cumulative flow data from the broader campaign, demonstrate that the field is capable of sustaining the gas volumes required to operate the helium plant at efficient capacity once wells are tied into the plant”.
Next steps include tying the new wells into the processing plant over the coming months. Once production-ready, total gas flow is expected to support Phase 1 nameplate capacity. Production will ramp in line with customer demand and offtake agreements, with discussions ongoing for LNG and liquid helium supplies. Phase 1 targets output of 2,500 GJ per day of LNG and 58 MCF per day of liquid helium upon completion in 2026.
As we’ve thoroughly tracked, this progress builds directly on the company’s acquisition of Renergen. Following regulatory clearance reported here in December 2025, the deal integrated high-concentration helium assets into ASPI’s portfolio of critical materials. Helium serves not only as a vital input for semiconductors, quantum computing, medical imaging, and space applications but also as a carrier gas in the company’s proprietary isotope enrichment processes.
Readers will recall our earlier coverage of ASP Isotopes’ Silicon-28 supply contracts and U.S. radiopharmacy acquisition in October 2025, the private placement backed by funds linked to Eric and Donald Trump Jr. in November, and more recent advances including a major nuclear operator MOU and progress toward commercial uranium enrichment. This latest update on the helium front further diversifies ASPI’s exposure across nuclear fuel, medical isotopes, quantum materials, and now reliable helium supply amid global constraints, including disruptions tied to Qatar production.
Read the full article here